Sight Sciences, Inc. (SGHT)
NASDAQ
Key stats Fiscal year 2025
Income statement
- Revenue
- 77,363,000 -3.1%
- Net income
- -38,426,000
- Gross profit
- 66,666,000
- Operating income
- -37,099,000
- Earnings per share
- -0.74
- R&D expense
- 14,606,000
Growth and profitability
- Gross margin
- 86.17
- Operating margin
- -47.95
- Net margin
- -49.67
- Return on equity
- -60.10
- Return on assets
- -33.33
- Free cash flow margin
- -38.67
Balance sheet
- Total assets
- 115,300,000
- Total liabilities
- 51,358,000
- Shareholders' equity
- 63,942,000
- Cash and equivalents
- 91,965,000
- Debt
- 42,380,000
- Net debt
- -49,585,000
- Current ratio
- 10.22
- Debt to equity
- 0.66
Cash flow and ratios
- Operating cash flow
- -29,694,000
- Free cash flow
- -29,918,000
Shareholder returns
- Shares outstanding
- 55,578,977
- Book value per share
- 1.15
Company information
- Headquarters
- Menlo Park, CA
- Exchange
- NASDAQ
- Fiscal year end
- 12-31
- Industry (SEC)
- Surgical & Medical Instruments & Apparatus
Fiscal year end: · Source: SEC EDGAR
Sight Sciences, Inc. trades on NASDAQ under the ticker symbol SGHT. This page brings together its price chart, company profile, key financial figures and technical indicators.